BT. Short-term magnesium deficiency upregulates ceramide synthase in cardiovascular tissues and cells: crosstalk among cytokines, Mg 2ϩ , NF-B, and de novo ceramide. Am J Physiol Heart Circ Physiol 302: H319 -H332, 2012. First published October 7, 2011 doi:10.1152/ajpheart.00453.2011.-The present study tested the hypotheses that 1) short-term dietary deficiency (MgD) of magnesium (21 days) would result in the upregulation of ceramide synthase (CS) in left ventricular (LV), right ventricular, atrial, and aortic smooth muscle, as well as induce a synthesis/release of select cytokines and chemokines into the LV and aortic smooth muscle and serum; 2) exposure of primary cultured vascular smooth muscle cells (VSMCs) to low extracellular Mg concentration would lead to the synthesis/release of select cytokines/chemokines, activation of N-SMase, and the de novo synthesis of ceramide; and 3) inhibition of CS by fumonisin B1 (FB1) or inhibition of neutral sphingomyelinase (N-SMase) by scyphostatin (SCY) in VSMCs exposed to low Mg would result in reductions in the levels of the cytokines/chemokines and lowered levels of ceramide concomitant with inhibition of NF-B activation. The data indicated that shortterm MgD (10% normal dietary intake) resulted in the upregulation of CS in ventricular, atrial, and aortic smooth muscles coupled to the synthesis/release of 12 different cytokines/chemokines, as well as activation of NF-B in the LV and aortic smooth muscle and sera; even very low levels of water-borne Mg (e.g., 15 mg·l Ϫ1 ·day Ϫ1 ) either prevented or ameliorated the upregulation and synthesis of the cytokines/chemokines. Our experiments also showed that VSMCs exposed to low extracellular Mg resulted in the synthesis of 5 different cytokines and chemokines concomitant with synthesis/release of ceramide. However, inhibition of the synthesis and release of ceramide by either FB1 or SCY attenuated, markedly , the generation of ceramide, release of the cytokines/chemokines, and activation of NF-B (as measured by activated p65 and cRel). cardiac muscle; vascular muscle; p65; cRel; neutral sphingomyelinase; water-borne magnesium IMPROPER NUTRITION, HIGH CHOLESTEROL intake, and fatty diets are known to promote lipid deposition and accelerate growth and transformation of smooth muscle cells (SMCs) in the vascular wall (20, 40, 57) . Over the past five decades, an accumulation of epidemiological and experimental data have indicated that a reduction in the dietary intake of Mg, as well as low Mg content in drinking water, is a risk factor for the development of hypertension, atherosclerosis, vasospasm, sudden cardiac death, stroke, and inflammatory conditions by ill-defined mechanisms (e.g., see Refs. 1, [4] [5] [6] [17] [18] [19] [27] [28] [29] 35, 38, 46, 48, 49, 63, 64, 65, 67, 72) . Hypermagnesemic diets have been shown to ameliorate hypertension and atherogenesis (4, 5, 7, 8, 18, 23, 67) . At present, the average dietary intake of Mg has declined from ϳ450 -485 mg/day in 1900 to ϳ185-235 mg/ day for large segments of the North American population (4, 30, 56). Furthermore, the myocardial level of Mg has consistently been observed to be lower in subjects dying from ischemic heart disease in soft-water areas than in subjects living in hard-water areas (4, 6, 27-29, 46, 48, 63-65, 67, 72).
IMPROPER NUTRITION, HIGH CHOLESTEROL intake, and fatty diets are known to promote lipid deposition and accelerate growth and transformation of smooth muscle cells (SMCs) in the vascular wall (20, 40, 57) . Over the past five decades, an accumulation of epidemiological and experimental data have indicated that a reduction in the dietary intake of Mg, as well as low Mg content in drinking water, is a risk factor for the development of hypertension, atherosclerosis, vasospasm, sudden cardiac death, stroke, and inflammatory conditions by ill-defined mechanisms (e.g., see Refs. 1, 4 -6, 17-19, 27-29, 35, 38, 46, 48, 49, 63, 64, 65, 67, 72) . Hypermagnesemic diets have been shown to ameliorate hypertension and atherogenesis (4, 5, 7, 8, 18, 23, 67) . At present, the average dietary intake of Mg has declined from ϳ450 -485 mg/day in 1900 to ϳ185-235 mg/ day for large segments of the North American population (4, 30, 56 ). Furthermore, the myocardial level of Mg has consistently been observed to be lower in subjects dying from ischemic heart disease in soft-water areas than in subjects living in hard-water areas (4, 6, 27-29, 46, 48, 63-65, 67, 72) .
With the use of sensitive ion-specific Mg 2ϩ -selective electrodes, it has been found that patients with hypertension, ischemic heart disease, stroke, atherosclerosis, and certain inflammatory conditions exhibit a significant depletion of serum/plasma ionized, but not total, Mg (5, 6, 17, 19, 35, 64, 67) . Dietary deficiency of Mg in rats and rabbits has been demonstrated to cause vascular remodeling concomitant with hypertension and atherosclerosis (i.e., arteriolar wall hypertrophy and alterations in the matrices) of unknown origin (7, 8, 18, 23, 45) .
As early as 15 years ago, using cerebral and peripheral vascular smooth muscle cells (VSMCs) in primary cultures, it was demonstrated that variation in free extracellular Mg 2ϩ concentration ([Mg 2ϩ ] o ) causes sustained alterations in membrane phospholipids and second messengers as well as activation of several signal transcription molecules, identical to those mentioned above (13, 54, 55) . Such paradigms, using variations in Mg 2ϩ , also cause membrane oxidation, truncation of membrane fatty acids, and the activation of apoptotic pathways (i.e., caspase-3, apoptotic protease activation factor-1, and release of mitochondrial cytochrome c) concomitant with the significant activation of neutral sphingomyelinase (N-SMase) and alterations in membrane sphingomyelin (SM), leading to the release of ceramides in cultured VSMCs (14 -16, 68) . Very recently, using a short-term (21 days) rat model of dietary MgD, we noted decreased levels of serum SM, lipid peroxidation, and fragmentation of DNA coupled with generation of the tumor suppressor-transcription factor p53 in the left ventricular (LV) and right ventricular (RV) muscles as well as in atrial muscle and vascular smooth muscle (14, 16) . These alterations (including the change in serum SM) were highly correlated (P Ͻ 0.01) with the levels of serum ionized Mg levels (14, 16, 68) .
The de novo synthesis of SM is brought about via the action of serine palmitoyl-CoA transferase (SPT), 3-ketosphinganine reductase, ceramide synthase (CS), dihydroceramide desaturase, and SM synthase (SMS; Ref. 74) . SMS requires phosphatidylcholine (PC) and ceramide as substrates to manufacture SM and diacylglycerol (DAG; see Ref. 74) . This reaction directly affects SM, PC, and ceramide as well as DAG levels. Three of us (55) have previously noted, using primary cerebral and peripheral VSMCs in culture, that a variation in [Mg 2ϩ ] o influences the cellular levels of SM, PC, DAG, and ceramide. Ceramide, either released as a consequence of SMase acting on SM and/or activation of either SPT or SMS or activation of CS, is now thought to play important roles in fundamental pathophysiologic processes such as cell proliferation, membrane receptor functions, angiogenesis, microcirculatory functions, immune inflammatory responses, cell adhesion, atherogenesis, senescence, programmed cell death (12, 21, 22, 24, 31, 33, 36, 44, 58, 59, 73, 79, 82, 83) , as well as cellular membrane transport and distribution of Mg 2ϩ in VSMCs (82) . Although the activation of N-SMase, SPT-1, and SPT-2 as well as SMS by low [Mg 2ϩ ] o results in (and ensures) ceramide production in cardiovascular tissues (14 -16) , the activation of CS by low [Mg 2ϩ ] o could result in additional levels of de novo ceramide. No direct information exists, however, on the potential latter pathway of activation by low [Mg 2ϩ ] o in cardiovascular tissues and/or cells. However, using primary cerebral and peripheral VSMCs in culture, exposed to low[Mg] o , we have found that a specific (and selective) inhibitor of CS, namely fumonisin B1, resulted in a marked reduction in de novo synthesis of ceramide (15) , presumably suggestive of an upregulation of CS. Whether a dietary deficiency of Mg results in upregulation of CS is not known. Recently, CSs have been characterized by a family of at least six different isoforms (69) . Initially, they were named longevity assurance (LASS) genes (62) . Since CS appears to be localized in the endoplasmic reticulum (69) , it can effect links to cell membrane structures and affect many cell functions. We hypothesized that short-term Mg deficiency (MgD) in 1) intact rats would upregulate CS activities in cardiac and vascular smooth muscles; and 2) imbibing low levels of a water-soluble Mg salt in drinking water would inhibit or reverse the predicted effects of dietary deficiency upregulation of CS.
Leukocytes and endothelial cells as well as VSMCs can modulate inflammatory conditions via the elaboration and release of cytokines and chemokines (37, 43, 70, 71) . MgD has been shown in rats to result in upregulation of interleukin-1 (IL-1␣), IL-6, and TNF-␣ in serum and endothelial cells (76) . These pleiotropic cytokines have been implicated in atherogenesis, hypertension, and numerous immune-inflammatory pathways (37, 71) . Certain cytokines and chemokines, however, are anti-inflammatory and vital in wound healing [e.g., interferon-␥ (IFN-␥), IL-4, IL-8, IL-10, Il-12, IL-13, granulocyte-macrophage colony stimulating factor (GM-CSF), transforming growth factor-␤ (TGF-␤), and regulated upon activation, normal T expressed and secreted (RANTES), among others; Refs. 37, 39, 71] . Although cytokine secretion has been, and is, a widely studied process, specific mechanisms for regulation of cytokine (and chemokine) release still remain to be determined (37, 71) . Interestingly, cytokines have recently been implicated in the generation/release of ceramide (32, 59) as well as the activation of SMases (41, 59) . We hypothesized that 1) de novo generation of ceramide in short-term MgD (14) would upregulate and release several cytokines and chemokines into sera of such animals and in primary cultured VSMCs; 2) imbibing low levels of a water-soluble Mg salt in drinking water would inhibit or reverse the predicted effects of dietary deficiency of Mg on the upregulation and release of the cytokines and chemokines; 3) blockage of de novo synthesis (with a specific inhibitor of CS) in primary cultured VSMCs would result in an attenuation of the generation of select cytokines/chemokines in these vascular cells; and 4) blockage of low [Mg 2ϩ ] o -induced activation of N-SMase would result in reduced levels of ceramide and an attenuation of the generation of select cytokines/chemokines.
Nuclear factor-B (NF-B) is now known to be a prime regulator of growth processes, differentiation, cell migration, and cell death (for review, see Ref. 39) . NF-B is a transcription factor and a pleiotrophic regulator of numerous genes involved in inflammatory processes (37) . NF-B is thought to be a pivotal transcription factor in atherogenesis and hypertension (26, 53, 71) . It is not clear as to what factor(s) initiates expression of these molecular and cellular events. Recently, we (11, 13) have reported in preliminary experiments that shortterm exposure of cerebral and peripheral VSMCs to low [Mg 2ϩ ] o results in an upregulation of several DNA-binding proteins involved in activation of NF-B. Some studies (66) also suggest that NF-B activation may be triggered by a release/generation of ceramide. However, there is also some evidence, in certain cells, that ceramide may not be necessary for NF-B activation (32) .Moreover, several lines of evidence suggest that ceramides are important in cytokine generation and in cytokine-induced apoptosis (39, 71) . We designed experiments with primary culture of VSMCs to determine whether upregulation of CS (and de novo synthesis of ceramide; e.g., Ref. 16 ) and activation of N-SMase and generation/release of ceramide (14 -16) , induced by low [Mg 2ϩ ] o , are associated with activation of NF-B and release/generation of cytokines and/or chemokines in the vascular cells.
MATERIALS AND METHODS
Animals, diets, sera, and organ-tissue collections. Mature male and female rats (200 Ϯ 65 g) were used for all experiments. All experiments were approved by the Animal Use and Care Committee of the State University of New York Downstate Medical Center. Equal numbers of paired male and female animals were used for all nutrition experiments. Control (600 ppm Mg) and MgD (60 ppm Mg) pellet diets were obtained from DYETS (AIN-93 G diets; Bethlehem, PA). All animals were given their respective diets for 21 days as previously described (14, 16) . MgD animals were allowed to drink triply distilled water (Mg 2ϩ Ͻ 10 Ϫ6 M) containing one of four different levels of Mg aspartate-HCl (0, 15, 40, or 100 mg/l Mg; Verla Pharm, Tutzing, Germany). All control animals received a normal Mg-containing diet (i.e., 600 ppm) as well as triply distilled water to drink. On the 22nd day, sera and tissues (the LVs and RVs, atria, abdominal aorta between the superior mesenteric arteries, and renal arteries, cleaned of all connective tissues) were collected quickly after anesthesia (45 mg/kg im pentobarbital sodium). Tissues were stored rapidly under liquid nitrogen (Ϫ85°C) until use. Whole blood was collected under anaerobic conditions in red-stoppered (no anticoagulant present) tubes, allowed to clot under anaerobic conditions, and then centrifuged under anaerobic conditions in capped vacutainer tubes. The sera were then collected into additional red-stoppered tubes under anaerobic conditions for processing shortly thereafter, similar to previously described methods (14, 17) . Serum samples were then analyzed within 2 h after collection, as previously described (14, 17) . Total Mg levels were measured by standard techniques in our laboratory (Kodak DT-60 analyzer; Ektachem Colorimetric Instruments, Rochester, NY). The method compares favorably with atomic absorption techniques for total Mg (17) . A Mg 2ϩ -selective electrode with a novel neutral carrier-based membrane (NOVA 8 Analyzer; NOVA Biomedical Instruments, Waltham, MA) was used to measure the free divalent cation in the sera (17) . The ion-selective electrode was used in accordance with established procedures developed in our laboratory having an accuracy and precision of 3% (17) .
Biochemical measurements of CS in tissues and sera. For the direct ELISA CS assay employing a goat anti-rat LASS3 polyclonal antibody-unconjugated (Abcam, Cambridge UK), multiple steps were required as follows. Before generating a lysate, the tissues (stored under liquid N 2) were first cut into small cubes and then transferred into a hand homogenizer using 3 ml ice-cold RIPA buffer per gram of tissue (RIPA buffer consisted of 20 mM Tris·HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS with freshly added PMSF, with freshly added aprotinin and leupeptin to 5 ug/ml just before use). The tissues were kept in the RIPA buffer on ice for 10 min before homogenizing by then pushing the piston slowly into the mixture via a continuous twisting. The tissues were kept submerged in the ice during the homogenization process. The procedure was repeated until the tissues were liquefied. The liquefied tissue samples were then divided into 1.5-ml tubes and centrifuged for 3 min at 4°C. The clear supernatants were next transferred into new tubes, removing ϳ20 ul for protein determinations (via BCA protein determination kits). The lysates were then brought to 5 mg/ml by addition of ice-cold RIPA buffer and then stored in liquid N 2 until use.
The antigen was diluted to a final concentration of 20 ug/ml in PBS buffer (1.16 g Na2HPO4, 0.1 g KCl , 0.1 g K3PO4, and 4.0 g NaCl pH 7.4). The wells of a PVC microliter plate were coated with the antigen. A polyclonal LASS3 antibody, diluted to the optimal concentration (Abcam) in blocking buffer (1% BSA, serum, nonfat dry milk, casein, and gelatin in PBS), was added immediately before use. The CS was analyzed according to the procedures outlined in the ELISA CS assay kit (Abcam). The absorbance (optical density) of each well was read with a plate reader. Standard curves were used to measure the concentrations of the enzyme.
Assay of cytokines and chemokines. Sera and tissues were harvested from the control and MgD animals, as described above, and kept frozen until biochemical analysis. Multi-Analyte ELISArray kits (SA Biosciences, Frederick, MD) designed for rats were used for the quantitative measurement of 12 different cytokines and chemokines (i.e., IL-1␣, IL-1␤, IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, IFN-␥, TNF-␣, GM-CSF, and RANTES). We read the absorbances at 450 nm within 30 min of stopping the reaction. Standards were used, standard curves were plotted, and the experimental cytokine/chemokine values were calculated.
Isolation of vascular muscle and primary culture of aortic VSMCs. Rat aortic VSMCs were isolated according to established methods (13, 81) in our laboratory (n ϭ 10 -12 animals/group) and cultured in DMEM containing 1.2 mmol/l [Mg 2ϩ ]o, FCS, and antibiotics at 37°C in a humidified atmosphere composed of 95% air-5% CO2 (55, 81) . After confluence had been reached, VSMCs were placed in media containing either 0.3, 0.6, or 1.2 mmol/l [Mg 2ϩ ]o for varying periods of time (2 or 24 h). It should be stressed that the experiments using cell cultures and those below on primary VSMCs in culture were never part of the whole animal nutritional experiments (described above); these experiments and others were separate from the nutritional experiments. Where appropriate, the select cytokine (i.e., IL-1␤, IL-6, IL-8, and TNF-␣) and chemokine [monocyte chemoattractant protein-1 (MCP-1)] concentrations were measured in the VSMCs (with and without fumonisin B1) using ELISA with specific antibodies and methods we (10) have recently reported for other cell types. Some of the experiments using the primary VSMCs examined the changes in cellular MCP-1, as this particular chemokine has been demonstrated to play major roles in monocyte recruitment and is implicated in atherogenesis (37) . The major cells in the vascular walls (i.e., endothelial, VSMCs, and macrophages) all have been shown to contribute to overexpression of MCP-1 in atherosclerotic tissues.
Influence of an inhibitor (fumonisin B1) of CS on the de novo
NF-B expression in cardiovascular tissues and primary cultured VSMCs. Briefly, for the primary aortic smooth muscle cells, we utilized EMSA similar to that we performed in our laboratory previously (11) . Nuclear protein extracts were separated by SDS/PAGE on 7.5% (wt/vol) polyacrylamide gels made in a buffer containing a Tris/boric acid/EDTA mixture (11) . Electrophoresis was performed at a constant voltage of 100 V for 90 min at 4°C. For the supershift assays, nuclear proteins were incubated with antibodies specific for the known NF-B components (p50, p52, p65, RelB, and cRel; Santa Cruz Biotechnology, Santa Cruz, CA) before ␥-32 P labeled (11) . NF-B oligonucleotides were added as described previously (11) . To verify that activation of NF-B was in fact the result of incubation in low [Mg 2ϩ ]o (with/without inhibitors), separate groups of VSMCs were exposed to the prototypical NF-B inhibitor pyrrollolidine dithiocarbamate (PDTC; 0.1 uM; Refs. 11, 39).
For measurement of NF-B in ventricular and aortic smooth muscle obtained from MgD animals, we utilized a highly sensitive ELISA kit recently developed for numerous high-through-put sampling (TransAM NF-B family transcription factor assay kit; Active Motif North America, Carlsbad, CA). As in the case for the primary cultured aortic smooth muscle cells, this kit assays for p50, p52, p65, RelB, and cRel subunits. [Mg 2ϩ ]o,, PDTC, and funonisin B1. To determine whether IB phosphorylation (and degradation) is stimulated by low concentrations of [Mg 2ϩ ]o (as a possible consequence of CS activation), the VSMCs were incubated for 18 h and IB breakdown was assayed using a highly specific rabbit IB antibody (Santa Cruz Biotechnology; Ref. 11). ]o with or without 75 uM scyphostatin (SigmaAldrich) for 18 h. We extracted the lipids in the cells as we have detailed elsewhere (54, 55) . The ceramide was next converted into ceramide-1-[ 32 P]phosphate by Escherichia coli DAG kinase, and the lipids were separated on high-performance TLC plates as described elsewhere (16, 58) . After autoradiography, spots corresponding to ceramide-1-phosphate were carefully scraped into vials, and the radioactivity was counted in a scintillation counter (LS-6500; Beckman). Quantitation of ceramide levels and results as picomoles per 10 8 cells were determined (16) .
Measurement of IB degradation and NF-B activation in primary cultured aortic smooth muscle cells exposed to low

Influence of an inhibitor (scyphostatin) of N-SMase on ceramide levels, select cytokines and chemokines, and NF-B expression in
Where appropriate, the select cytokine and chemokine concentrations were measured in the VSMCs (with and without scyphostatin) as above.
Expression of NF-B levels (with and without scyphostatin), using the p65 and cRel subunits, was measured as per the methods described above.
Statistical analyses. Where appropriate, means and means Ϯ SE were calculated. Differences between means were assessed for statistical significance by Student's t-tests and ANOVA followed by a Newman-Keuls test. In some cases, correlation coefficients were calculated by the method of least squares. P values of Ͻ0.05 were considered significant.
RESULTS
Influence of diet on water consumption and food intake and overall physiological condition. As shown recently, using an identical dietary regimen of Mg in controls and MgD animals (14) , there were no significant differences in either water consumption or food intake between the diverse subgroups of rats (i.e., controls ϭ 600 ppm Mg, MgD, MgD ϩ 15 mg·l ). All of the MgD subgroups (n ϭ 18 -30 animals per group), irrespective of the amount of Mg in the diets or in the drinking water, showed no loss in gait or any other outward signs of pathology or behavior.
Serum total and ionized Mg levels. Feeding the animals the synthetic AIN-93G pellet diet (n ϭ 18 -30/group) resulted in a total serum Mg level of 1.00 mM/l, whereas the animals receiving the MgD diet exhibited a serum total Mg level of 0.38 Ϯ 0.004 mM/l (P Ͻ 0.01). The serum level of ionized Mg in the normal, control group was 0.60 Ϯ 0.002 mM/l, whereas in the MgD group the serum ionized level was reduced to 0.30 Ϯ 0.003 mM/l (P Ͻ 0.01).
Feeding the MgD animals various levels of Mg in their drinking water (as seen previously, Refs. 14, 15) resulted in concentration-dependent rises in both the total and ionized levels of serum Mg. The 100 mg·l Ϫ1 ·day Ϫ1 of Mg 2ϩ elevated the total Mg level to normal, i.e., 0.98 Ϯ 0.004 mM/l, whereas feeding 15 and 40 mg·l Ϫ1 ·day Ϫ1 of Mg in the drinking water raised the total Mg levels to 67 (0.66 Ϯ 0.003 mM/l) and 83% (0.81 Ϯ 0.006 mM/l), respectively, of normal (n ϭ 18 -26; P Ͻ 0.05). With respect to the serum ionized levels, feeding the animals 100 mg·l Ϫ1 ·day Ϫ1 of Mg restored the level of ionized Mg to normal while feeding 15 and 40 mg·l Ϫ1 ·day Ϫ1 of Mg to the rats raised the serum ionized levels to 60% (0.38 Ϯ 0.004 mM/l) and 65% (0.42 Ϯ 0.004 mM/l), respectively, of normal (n ϭ 18 -26; P Ͻ 0.05).
Influence of dietary Mg intake on CS levels in cardiac and vascular smooth muscles: relationship to serum ionized Mg. Figure 1 shows that feeding rats a MgD for 21 days resulted in an almost 300% rise CS enzymatic activity in LV and aortic smooth muscle and over a 200% rise in CS activity in RV and atrial muscle. Interestingly, feeding the MgD animals as little as 15 mg/l Mg 2ϩ in drinking water in LV, RV, and aortic smooth muscle reduced the rises in CS levels produced in animals fed the MgD diets, whereas 40 mg/l Mg 2ϩ in drinking water prevented the rises in CS activities in cardiovascular tissues. Although not shown, we found high degrees of correlation between the falls in serum ionized Mg and the rises in the enzymatic activities of CS; the lower the serum Mg 2ϩ , the greater the elevation in activities of CS in all of the cardiovascular tissues studied (r ϭ 0.78 -0.96; P Ͻ 0.01). There were either no (P Ͼ 0.05) or weak correlations (e.g., 0.26 -0.37) between total serum Mg and CS (data not shown). Table 1 demonstrates that 21 days of short-term MgD results in a 100% increase in serum CS activity. Although 15 mg/l of Mg added to the drinking water did not prevent the rise in CS activity, 40 mg/l of Mg in the drinking water completely prevented the rise in CS caused by the MgD.
Influence of dietary MgD with and without Mg supplementation on CS activity in sera.
Influence of dietary Mg intake on serum cytokine and chemokine levels: relationship to serum ionized Mg. Figure 2 demonstrates that feeding rats the MgD diet for 21 days resulted in 4-to 16-fold rises in the serum levels of the cytokines and chemokines, with the greatest rises in activities observed in IL-1␣ (ϳ16-fold), RANTES (ϳ13-fold), TNF-␣ (ϳ9-fold), GM-CSF (ϳ9-fold), and IL-10 (ϳ8-fold). Feeding the MgD animals 15-40 mg/l Mg 2ϩ in the drinking water largely prevented the rises in serum levels of all 12 cytokines and chemokines (Fig. 2) . Linear regression analyses demonstrated strong correlations between the reduction in serum ionized Mg and cytokine (and chemokine) levels (r ϭ 0.85-0.96; e.g., see Fig. 3 ). However, there were either no or weak (e.g., r ϭ 0.28 -0.42) correlations of total serum Mg to serum cytokine and chemokine levels (data not shown).
Influence of dietary Mg intake on cytokine and chemokine levels in LV and aortic muscle. Table 2 (Table 2) . Interestingly, exposure of the VSMCs to the CS inhibitor also resulted in a marked reduction in the expression of the p65 and cRel elements of NF-B (Fig. 6) as well as cytokine levels in the VSMCs (Table 3) . Interestingly, neither the p50, p52, nor the RelB subunits of NF-B were significantly altered by either exposure to low Mg 2ϩ or the CS inhibitor (data not shown; P Ͼ 0.05).
The data illustrated in Table 3 (Table 4) . Use of the N-SMase inhibitor also resulted in a reduction in the generation of the p65 and cRel subunits of NF-B (Fig. 6 ) as well as cytokine levels ( Table 5) .
The data shown in Table 5 Values are means Ϯ SE; n ϭ 8 -10 each. All values except MG deficient (MgD) ϩ 15 are significantly different from MgD alone (P Ͻ 0.01 by ANOVA). 
Mg
2ϩ in the drinking water in both the LVs and aortas (obtained from the intact animals) reduced the expression of both p65 and cRel subunits of NF-B (Figs. 7 and 8) . Table 6 indicate that treatment of VSMCs with PDTC did indeed inhibit low [Mg 2ϩ ] o -induced IB breakdown. Addition of fumonisn to the VSMCs exposed to low [Mg 2ϩ ] o also attenuated the breakdown of IB but to a lesser extent than PDTC. Fig. 9 using multiple regression analysis indicates high degrees of correlation of serum CS activity, serum ionized Mg, and ventricular and aortic muscle cytokines/chemokines (P Ͻ 0.001).
Influence of PDTC on IB degradation and p65 activation in the nuclei of low [Mg 2ϩ ] o -treated primary cultured aortic VSMCs with and without exposure to fumonisin B1. The data shown in
Multiple regression analyses and correlations of serum CS activity and serum ionized Mg with ventricular (and aortic muscle) cytokines and chemokines obtained from MgD animals. The data summarized in
DISCUSSION
The results reported, herein, are the first demonstration that short-term dietary deficiency of Mg in an intact mammal results in activation of CS in diverse cardiovascular tissues and cells. To our knowledge, this is the first time anyone has shown an upregulation of CS by MgD in any cell type in any species. The de novo pathway of sphingolipid synthesis has gained considerable attention over the past decade (34, 47, 52, 61) . CSs are important proteins of the endoplasmic reticulum (69). The molecular pathways via which ceramides are synthesized are known to be highly conserved between yeast and mammals (69) . Six homologs of CS are known to exist in mammals (69), which were initially termed LASS genes, but recently changed to CS. CS catalyzes the formation of ceramide from the precursor sphinganine in the sphingolipid pathway. The mycotoxin fumonisin B1 used in the present studies inhibits this major step in the generation of ceramide (75) . We show in the present study that inhibition of CS by fumonisin B1 results in a marked reduction in the de novo synthesis of ceramide (as measured by the uptake of [ 3 H]palmitic acid) in primary aortic smooth muscle cells.
Our experiments confirm and add further support to the concept that lowered levels of Mg can lead to the formation of ceramide in cardiovascular tissues and cells (55) . We also confirm that ceramide synthesis in cardiovascular tissues and cells is, at least, in part, a result of activation of CS and N-SMase (14 -16, 55) . When taken together with previous findings from our laboratories, it becomes clear that the de novo synthesis and generation of ceramides in cardiovascular tissues and cells, exposed to low [Mg 2ϩ ] o environments, are due to the action of at least four enzymes, namely, CS, N-SMase, SPT, and SMS.
It is now, generally, accepted that ceramides can be produced in many types of cells and tissues when they are exposed to ultraviolet radiation, endotoxins, retinoic acid, ionizing radiation, balloon injury of arterial vessels, phorbol esters, serum deprivation, daunorubicin, apoptotic signals, as well as cytokines, among other agents (21, 24, 33, 36, 44, 59, 73) . Many of these agents, including cytokines, are known to activate SPT, SMS, SMases, and CS to produce ceramides in many cell types (31, 69, 71) . The present findings support our previous suggestion (14 -16) that MgD should be added to the list of stimuli known to activate CS and N-SMase pathways, at least in rat cardiovascular tissues and VSMCs. One of the most important, key pathways leading to ceramide generation is via the CS homologs, which act to acylate sphinganine to produce ceramide (69) . Previously, we have shown that the production of low- [Mg 2ϩ ] o environments, either in vivo (e.g., identical model of MgD used here; Refs. 15, 16) or in primary cultured vascular cells (15, 55) , results in the activation of SMase, SMS, and SPT (SPT-1 and SPT-2) and the production of ceramides. Thus the present findings, when taken together with the latter studies, indicate that ceramide is most likely generated in cardiovascular tissues and cells in low [Mg 2ϩ ] o by four major enzymes in the sphingolipid pathway.
We believe the new experiments shown, herein, support our previous suggestions that the exposure of cardiovascular tissues to low [Mg 2ϩ ] o environments can result in sizable quantities of ceramides and could be responsible, in large measure, for activation of apoptotic events seen in MgD animals (14) as well as many of the structural, cellular, and lipid dysfunctional changes noted in atherogenesis and hypertension. It is of interest to note that the cytokines (e.g., IL-1␤, IL-6, IL-8, and TNF-␣, among others) documented to play important roles in apoptotic events are shown, herein, to be generated by at least two key enzymes (i.e., CS and N-SMase) needed for the synthesis of ceramides. In addition, it should be pointed out that many of the cytokines/chemokines found to be released by low Mg, herein, are known to be activated/generated in atherogenesis (37, 39, 71) . It is now accepted that apoptotic events play major roles in the development of atherogenesis and hypertension. However, up until our recent studies, it has not been possible to determine whether MgD-induced pathophysiological changes in the cardiovascular system are linked to alterations in sphingolipid metabolism. A key function of ceramide's role in pathophysiological actions is its ability to induce cell differentiation and transformation (33, 36, 58, 73) . Abnormal cell differentiation, transformation, and growth are pivotal events in the development of both atherogenesis (20, 40, 57,) and hypertension (40, 57) . Hyperplasia and cardiovascular hypertrophy are common events in hypertension and key elements in target organ damage. However, the precise mechanisms regulating alterations in tissue mass, transformation of VSMC phenotypes, plaque formation in vascular walls, and lipid deposition are not completely understood. Cytokines/chemokines are now known to be generated/released in these cellular events along with activation of NF-B DNA-binding proteins, as well as activation of the tumor suppressor protein p53 (37, 71) . We believe it is more than coincidental that short-term MgD results in generation/release of at least 12 different, key cytokines and chemokines along with activation of the key NF-B DNA-binding proteins p65 and cRel (present work) and activation of p53 shown recently (16) . The latter protein is known to play critical roles in cell transformation, growth, and apoptotic events (50, 51) . It is important to note, here, that ceramide, p53, and activation of NF-B can induce cell cycle arrest (and senescence), induce programmed cell death, and are associated with DNA damage (genotoxic events). It has been demonstrated that MgD can produce all three of these pathophysiological events in several cell types, including cardiac and VSMCs (Refs. 6, 11, 13, 14 -16, 68, 81). Our present study suggests that MgD environments drive ceramide synthesis, at least in VSMCs, via the activation of two major enzymes in the sphingolipid pathway: CS and N-SMase. Some additional discussion of the potential relevance of the present findings, with the p65 and cRel proteins and the NF-B family, to atherogenesis are in order. The NF-B family of proteins is composed of five different and related transcription factors: c-Rel, RelB, p50, p52, and p65 (for recent review, see Ref. 39 ). Homo-and heterodimers are formed from these transcription factors, which share an N-terminal DNA-binding dimerization domain known as the Rel homology domain. These NF-B dimers can bind to a number of target DNA sequences termed B sites (which contain transcription activation domains) that allow coactivator recruitment and target gene expression (for review, see Ref. 39 ). Since p50 and p52 (not however activated by low Mg 2ϩ environments in the present work) are major players in the noncanonical pathway but lack transcription activation domains, they activate transcription by forming heterodimers with the p65, c-Rel, or RelB proteins (for review, see Ref. 39 ). NF-B plays a major role in the transcription of the genes encoding many proinflammatory cytokines and chemokines, analyzed herein, which also regulate the expression of adhesion molecules important in atherogenesis, an inflammatory syndrome (37, 39, 43, 70) . It is important to point out here that the cytokines (i.e., IL-1␤, IL-6, IL-8, and TNF-␣) and MCP-1, found to be elevated, herein, in VSMCs exposed to low [Mg 2ϩ ] o , are identical to those found in VSMCs, T cells, monocytes/macrophages, and endothelial cells in atherosclerotic plaques (for review, see Ref. 39 ). We do not believe this is a coincidence. Activation of the p65 and cRel proteins found in the present study, to be induced by low [Mg 2ϩ ] o , is pivotal in recruitment of leukocytes (39) and in several arms of the innate and adaptive immune systems in atherogenesis (37, 39) . Since MgD has been shown to result in accelerated atherogenesis in rabbits, which was shown to be associated with increased levels of leukocytes and p53 in the thickened atherosclerotic plaques (18), we hypothesize that p65 and cRel were first, more than likely, activated, at least in part, by synthesis and release of ceramides (via CS, SMases, SPT-1 and 2, and SMS) in the MgD environment, which would have then acted to activate and release cytokines/chemokines and growth factors. 14 -16, 68) . Interestingly, activated forms of NF-B have been reported to be present in VSMCs, macrophages, and endothelial cells of human atherosclerotic lesions (39, 71) .
Likewise, we hypothesize that many of the structural and adaptive vascular wall and blood flow disturbances seen in the arterioles and arteries in MgD-induced hypertension (7, 8, 45) are also, in large measure, a consequence of synthesis and release of sphingolipids and activation of NF-B. Even though it has been repeatedly demonstrated that prolonged administration of Mg 2ϩ (oral and intravenous) can lower arterial blood pressure in both experimental and clinical forms of hypertension (4 -6, 23, 45, 64, 67, 80) , the precise mechanism(s) is not known. It has been suggested, often, that Mg 2ϩ lowers blood pressure by promoting vasodilation and decreasing work load on the myocardium via direct actions on Ca 2ϩ channels (and cellular redistribution) in vascular and cardiac muscle cells (2, 3, 5, 7, 8, 23, 64, 67) . In view of our present study and those recently published (14 -16, 54, 55) , we believe that Mg's effects on ceramide and sphingolipid metabolism must now be taken into consideration in helping to explain the blood pressure-lowering actions of this divalent cation.
Our present findings that demonstrate activation of CS in LV and RV as well as atrial muscle coupled with elevation in serum levels of 12 different cytokines and chemokines, obtained from MgD animals, may have direct relevance to heart failure and sudden cardiac death syndromes. The potential roles of proinflammatory cytokines in these syndromes is gaining acceptance (25, 37, 43, 70, 71) . Interestingly, intravenous administration of either IL-1␤ or TNF-␣ (2 cytokines shown here to be elevated by low Mg) produce a profile of cardiac-hemodynamic failure; LV ejection and LV pressure volume indexes drop precipitously (25, 71) . Several of the cytokines shown, in the present work, to be elevated in sera from MgD animals (e.g., IL-1␣, IL-1␤, IL-2, IL-6, and TNF-␣) have been found to be associated with heart failure in humans (71) . Furthermore, the presence of rising plasma levels of IL-6 has been suggested to be a harbinger of impending morbity/ mortality in human subjects diagnosed with heart failure (71). Recently, secretory SMase was reported to be upregulated in chronic heart failure patients (for review, see Ref. 60 ). Extensive clinical studies over the past three decades have identified magnesium deficient states in thousands of patients in congestive heart failure, acute ischemic heart diseases, acute myocardial infarction, angina, and sudden cardiac death (for reviews, see Refs. 1, 4, 6, 38, 67) . In vitro studies from other laboratories (77) on perfused working rat hearts obtained from MgD animals and in vitro studies from our laboratories (9, 78) on perfused working rat hearts clearly demonstrate that even short-term MgD results in reduction in a variety of hemodynamic cardiac functions. Overall, these in vitro studies on perfused rat hearts demonstrate that short-term magnesium deficiency results in falls in cardiac output, coronary flow, stroke volume, developed pressures, and ischemia concomitant with a lowering of high-energy phosphate.
We believe it is important to point out here that while our experiments investigated various and numerous biochemical and molecular analytes in the LV and RVs and atria, these tissues are composed of not only myocytes (ϳ60%) but fibroblasts (ϳ27%), VSMCs (ϳ10%), and endothelial cells (ϳ7%). Over the past several decades, experimental and clinical evidence has been brought forth that suggests a striking linkage between dietary deficiency of Mg and diverse types of cardiovascular maladies, e.g., atherogenesis, hypertension, coronary artery disease, congestive heart failure, irregular heart rhythms, vasospasm, peripheral arterial diseases, myocardial infarction, diabetic-related vascular diseases, dyslipidemias, strokes, and sudden cardiac death (e.g., see Refs. 4, 6 -8, 14 -16, 23, 29, 38, 45, 46, 48, 49, 63, 64, 67, 72, 77) . More than 50 years ago, Kobayashi (42) showed in an epidemiological study that when the hardness of drinking water was elevated, the rate of death from cardiovascular diseases decreased. This concept has gained credibility over the past five decades from a large number of studies from different parts of our planet (4 -6, 27-29, 46, 48, 63, 67, 72) ; the death rates by sudden cardiac death are lower in hard-water areas than in soft-water areas. Despite the fact that the hardness of water is due to the concentration of Ca 2ϩ and/or Mg 2ϩ , the overwhelming evidence, to date, supports the idea that it is the Mg content that is responsible for most of the protective effects of hard water (28, 29, 38, 46, 48, 63) . More than 20 years ago, it was suggested that as little as 15-30 mg·l Ϫ1 ·day Ϫ1 of Mg 2ϩ in drinking water should be cardioprotective (46, 48) . Recently, 
Ϫ1
of Mg 2ϩ , in drinking water, either prevented or ameliorated the formation of reactive oxygen species, DNA fragmentation, caspase-3 activation, p53, mitochondrial release of cytochrome c, lipid peroxidation, activation of apoptosis, hydrolysis of sphingomyelin, upregulation of SPT-1 and SPT-2, and activation of SMS (14 -16 While the activation of CS and N-SMase and synthesis/ release of cytokines and chemokines most likely play important roles in the biological synthesis of ceramide and activation of the NF-B family of transcription factors in MgD, this could be one of many ways in which MgD is a cardiovascular risk factor. A few additional words with respect to the activation of CS by low [Mg 2ϩ ] o in the atria appear to be in order. The atria were the only organ tissues in which only high levels of [Mg 2ϩ ] o (i.e., 100 mg/l) added to the drinking water were able to prevent high degrees of CS stimulation (see Fig. 1 ). This finding is quite surprising and different from what is observed for activation of SPT 1, SPT 2, and SMS by low vs. high [Mg 2ϩ ] o in the atria (15, 16) . Dysfunction of the cardiac atria is well known to be a high-risk factor for induction of strokes. We believe it is, thus, possible that unabated generation of ceramides (acting to induce apoptosis and greater than normal relaxation) in atrial muscle via activation of CS by low [Mg 2ϩ ] o , despite eventual repletion of tissue Mg, may not overcome a prior activation of CS and be a risk factor for strokes. These findings and their potential clinical relevance merit future study.
We believe, at the very least, that this study, when viewed in light of previous recent studies ( 14 -16, 68) , adds considerable support for the hypothesis suggested more than two decades ago (46, 48) that water intake (e.g., from tap waters, well waters, bottled waters, and beverages using tap/well/spring waters) in humans varying between 1 and 2 l/day, with Mg 2ϩ intakes varying from Ͻ5 to Ͼ100 mg/l, may, as we have suggested recently (14 -16, 68) , represent an excellent way to overcome and control marginal intakes of Mg obtained with most Western diets. Moreover, in view of our previous findings and those presented here, it is probably propitious to suggest that all desalinated-purified recovered/recycled waters, harvested rain waters, well waters, tap waters, and all bottled waters given to humans should be supplemented with bioavailable Mg 2ϩ to ameliorate/prevent the induction of cardiovascular risk factors and disease processes worldwide.
